Oncology / Hematology
Oncology and Hematology billing requires exceptional precision because the specialty involves chemotherapy administration, infusion services, complex medication regimens, diagnostic imaging, pathology interpretation, and long term management of cancer and blood disorders. We ensure accurate ICD 10 CM diagnosis coding, CPT and HCPCS procedure coding, modifier accuracy, and compliant E/M service selection across inpatient, outpatient, and emergency department professional fee encounters. Our team reviews documentation for infusion therapy, injections, transfusions, bone marrow evaluations, treatment planning, and longitudinal cancer care to confirm medical necessity, drug administration details, and payer required elements are fully supported.
Oncology and Hematology denials often arise from missing drug waste documentation, incorrect infusion start/stop times, incomplete linkage between diagnoses and chemotherapy agents, and payer specific prior authorization failures. We address these issues by strengthening documentation workflows, validating diagnosis to drug alignment, and issuing provider queries when clarification is required. Our audits focus on identifying missed billable components such as hydration therapy, therapeutic add on codes, prolonged E/M services, and separately reportable injections that are frequently overlooked. We reinforce HIPAA compliance, documentation integrity, and payer policy adherence while optimizing pro fee charge capture across IP/OP/ED settings. Through targeted education and specialty specific denial analysis, we help oncology and hematology practices maintain a compliant, efficient revenue cycle that accurately reflects the full scope of cancer and blood disorder care.